Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma.

British journal of cancer - 1 Mar 1995

McKenna N J, Kieback D G, Carney D N, Fanning M, McLinden J, Headon D R

Abstract excerpt

Clinical outcome in ovarian carcinoma is predicted by progesterone receptor status, indicating an endocrine aspect to this disease. Peripheral leucocyte genomic DNAs were obtained from 41 patients with primary ovarian carcinoma and 83 controls from Ireland, as well as from 26 primary ovarian carcinoma patients and 101 controls in Germany. Southern analysis using a human progesterone receptor (hPR) cDNA probe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Base Sequence
Share to Chickens

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Deoxyribonucleases, Type II Site-Specific

Share to DNA, Neoplasm

Share to Molecular Sequence Data

Share to Ovarian Neoplasms

Share to Polymorphism, Restriction Fragment Length

Source

Open in PubMed Open full text

Identifiers

PMID: 7880723
DOI: 10.1038/bjc.1995.92
PMCID: PMC2033643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma.PMID 7880723Read ↗

Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.Semantic proximity Read ↗

Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion.Semantic proximity Read ↗

Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.Semantic proximity Read ↗

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.Semantic proximity Read ↗

Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients.Semantic proximity Read ↗

Analysis of the ERalpha germline PvuII marker in breast cancer risk.Semantic proximity Read ↗

Genetic variation in the progesterone receptor gene and ovarian cancer risk.Semantic proximity Read ↗

The influence of HER2 genotypes as molecular markers in ovarian cancer outcome.Semantic proximity Read ↗

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.Semantic proximity Read ↗

Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers.Semantic proximity Read ↗

A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.Semantic proximity Read ↗

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.